American Gastroenterological Association

Inflammatory Bowel Disease Expert and Harvard Medical School Faculty Dr. Hamed Khalili Joins Vivante Health’s Clinical Advisory Board

Retrieved on: 
Monday, February 26, 2024
Research, American Gastroenterological Association, Inflammatory Bowel Diseases, Education, Colorectal cancer, Physician, Quality of life, Hospital, Epidemiology, Gastrointestinal cancer, Vivante Corporation, American College, Inflammatory bowel disease, Associate, Massachusetts General Hospital, Harvard Medical School, Stanford University Medical Center, State, Nursing

CHICAGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Vivante Health , the employee benefit for GI care, announced the addition of Dr. Hamed Khalili to its Clinical Advisory Board today.

Key Points: 
  • CHICAGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Vivante Health , the employee benefit for GI care, announced the addition of Dr. Hamed Khalili to its Clinical Advisory Board today.
  • Dr. Khalili is a gastroenterologist and Director of Clinical Research at Massachusetts General Hospital, Crohn’s and Colitis Center and an Associate Professor at Harvard Medical School.
  • His research focuses on studying dietary and lifestyle factors and their relationship to the development and progression of inflammatory bowel diseases.
  • “Vivante Health is doing fantastic work to care for people with digestive conditions, particularly in the area of inflammatory bowel disease and other digestive conditions.

EMC Outdoor Announces the Addition of Dana Johnston as Vice President, Client Partnerships

Retrieved on: 
Tuesday, March 5, 2024
PAR, American Gastroenterological Association, McLarney, EMC, PCMA, ASAE, Organization, IDSA, Corporation

PHILADELPHIA, March 5, 2024 /PRNewswire/ -- EMC Outdoor is pleased to announce the appointment of industry veteran Dana Johnston as Vice President, Client Partnerships.

Key Points: 
  • Industry veteran Dana Johnston joins long-standing Out of Home and conference marketing specialist agency EMC Outdoor as Vice President, Client Partnerships.
  • PHILADELPHIA, March 5, 2024 /PRNewswire/ -- EMC Outdoor is pleased to announce the appointment of industry veteran Dana Johnston as Vice President, Client Partnerships.
  • Dana will help to strengthen our position as a leader in the industry and accelerate the development of key client relationships."
  • In her new role, Johnston will focus on developing new client relationships, expanding EMC's client portfolio, and driving success for her clients.

Peak Gastroenterology Associates Opens a New State-of-the-Art Facility to Better Serve the Denver Area

Retrieved on: 
Thursday, November 16, 2023
General Health, Other Health, Hospitals, Health, Practice Management, CO, American Gastroenterological Association, Peak, Patient, Nursing

Peak Gastroenterology Associates (“Peak” or “the Company”) is pleased to announce the grand opening of a new location in Lone Tree, CO.

Key Points: 
  • Peak Gastroenterology Associates (“Peak” or “the Company”) is pleased to announce the grand opening of a new location in Lone Tree, CO.
  • The general office and clinic will begin to see patients on November 16th and the connected endoscopy center is slated to open in late December.
  • The new space has specifically been designed to prioritize patient comfort, access, and convenience.
  • Peak, the fastest growing and largest gastroenterology practice in Southern Colorado, is a preferred partner of Gastro Care Partners.

Oshi Health Announces Agreement with WTW to Give Employers Access to Comprehensive Digestive Health Support for Their Employees

Retrieved on: 
Wednesday, December 6, 2023
WTW, 24/7 service, Food, Investment, Doctor of Pharmacy, American Gastroenterological Association, Patient, Clinical trial, Oshi, Aircraft, GI, Chantelle, Diagnosis, Partnership, ACG, Physician, Nursing

NEW YORK, Dec. 6, 2023 /PRNewswire-PRWeb/ -- With digestive health steadily increasing as a top cost category and growing concern among employers, Oshi Health, the virtual gastrointestinal (GI) clinic, today announces a partnership with WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company. Recognizing that digestive health issues are becoming a major cost issue and the quality of care is uneven, WTW embarked on a market analysis of solutions available and selected Oshi as a digestive health partner for WTW clients.

Key Points: 
  • Recognizing that digestive health issues are becoming a major cost issue and the quality of care is uneven, WTW embarked on a market analysis of solutions available and selected Oshi as a digestive health partner for WTW clients.
  • As a virtual GI center of excellence, Oshi Health provides employers with a total digestive health solution, delivering high-touch multidisciplinary care virtually and in partnership with local in-person providers to speed time to diagnosis, treatment, and symptom control.
  • They also demonstrated the transformational role employers can play in employees' digestive health and overall wellbeing by providing the program.
  • With Oshi, WTW clients will have easy access to digestive care that has been proven effective.

Gastroenterology Associates of North Mississippi Expands Access to GI Healthcare in Northern Mississippi through Partnership with Panola Medical Center.

Retrieved on: 
Friday, December 1, 2023
Health, American Gastroenterological Association, Patient, Gastroenterology, Travel, Partnership, Nursing

BATESVILLE, Miss., Dec. 1, 2023 /PRNewswire/ -- Gastroenterology Associates of North Mississippi (GANM) is excited to announce the expansion of its services to Panola Medical Center effective January 1st, 2024.

Key Points: 
  • BATESVILLE, Miss., Dec. 1, 2023 /PRNewswire/ -- Gastroenterology Associates of North Mississippi (GANM) is excited to announce the expansion of its services to Panola Medical Center effective January 1st, 2024.
  • The choice to extend services at Panola Medical Center reflects GANM's commitment to prioritizing local community care and accessibility.
  • Panola Medical Center CEO, Chris Ware, expressed enthusiasm for this partnership, stating, "We are thrilled to welcome Gastroenterology Associates of North Mississippi to Panola Medical Center.
  • This partnership with Panola Medical Center reflects GANM's longstanding mission to offer the highest quality healthcare within a compassionate, respectful, and caring environment.

Intoleran Prioritizes a Clean Digestive Enzyme Manufacturing Process

Retrieved on: 
Thursday, November 30, 2023
Enzyme, Starch, Digestion, HPMC, Research, Stomach, American Gastroenterological Association, Bloating, Fructose, Food intolerance, Crohn's disease, Calcium carbonate, Lactase, Nausea, Lactose, Extrapyramidal system, Animal feed, Dairy

FORT LAUDERDALE, Fla., Nov. 30, 2023 /PRNewswire/ -- There are many reasons an individual might struggle with digestive concerns. In 2022, the American Gastroenterological Association (AGA) reported new research revealing that as much as 40% of Americans suffer from "digestive troubles" on a daily basis. At times, this can be severe and can stem from serious medical concerns, such as celiac disease or Crohn's disease.

Key Points: 
  • "Food intolerance is typically a lack of digestive enzymes in the body," explains Harmen Treep, owner of Intoleran.
  • However, to be effective, enzymes must be clean and should not contain ingredients that complicate digestive issues.
  • "If a digestive enzyme comes with a lengthy ingredients list on the bottle, think twice," Treep warns.
  • The Intoleran owner uses his brand's lactase 10,000 digestive enzyme capsules as an example.

Top Gastroenterology and Liver Disease Specialist, Dr. David P. Yamini, Receives Castle Connolly's 2023 Top Doctor® Award

Retrieved on: 
Thursday, November 9, 2023
Hepatology, Irritable bowel syndrome, Disorder, American Gastroenterological Association, Stomach, Esophagus, ERCP, IBS, Liver, American College of Gastroenterology, Liver disease, Internal medicine, Indigestion, Patient, Multimedia, Gastrointestinal Endoscopy, Human, Santa Monica Boulevard, Castle Connolly Medical, Cedars-Sinai Medical Center, Pancreas, American College, Ulcerative colitis, Gallbladder, Crohn's disease, Gastroenterology, University, SIBO, Physician, Inflammatory bowel disease, Castle, Nursing, Film industry

BEVERLY HILLS, Calif., Nov. 9, 2023 /PRNewswire-PRWeb/ -- Dr. David Yamini has been selected as a 2023 Top Doctor® by Castle Connolly. Dr. Yamini is an accomplished physician who is double board-certified in gastroenterology and internal medicine. He serves patients in Santa Monica and Beverly Hills, CA, treating diseases and disorders of the digestive system. Dr. Yamini's medical education, training, hospital appointments and disciplinary history were rigorously screened by the Castle Connolly physician-led research team. Castle Connolly publishes its list of Top Doctors at http://www.castleconnolly.com and in a wide variety of partner publications, magazines and affiliate websites. Around 7% of the nation's top board-certified, licensed physicians have been selected as Castle Connolly Top Doctors in their regions for their specialties. Individuals do not and cannot pay to be selected as a Castle Connolly Top Doctor. Dr. David Yamini offers advanced diagnostic and therapeutic procedures and has established a reputation as one of the best Los Angeles gastroenterologists and liver disease specialists. Dr. Yamini offers expertise in issues involving the digestive tract, biliary system, liver and pancreas, with a proficiency in endoscopic retrograde cholangiopancreatography (ERCP). He takes a comprehensive approach to diagnosing and treating patients with all types of gastrointestinal (GI) problems and disorders that affect the small and large intestine, stomach, esophagus, gallbladder, liver and pancreas, including inflammatory bowel disease (Crohn's, ulcerative colitis), indigestion (dyspepsia), small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS). Dr. Yamini provides his patients with a superior level of compassionate and attentive personalized care.

Key Points: 
  • BEVERLY HILLS, Calif., Nov. 9, 2023 /PRNewswire-PRWeb/ -- Dr. David Yamini has been selected as a 2023 Top Doctor® by Castle Connolly.
  • Dr. Yamini's medical education, training, hospital appointments and disciplinary history were rigorously screened by the Castle Connolly physician-led research team.
  • Dr. David Yamini offers advanced diagnostic and therapeutic procedures and has established a reputation as one of the best Los Angeles gastroenterologists and liver disease specialists .
  • "It is such an honor to be recognized by my peers for this award," says Dr. David Yamini.

Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

Retrieved on: 
Thursday, November 9, 2023
Health, Diabetes, Neurology, Health Technology, Pharmaceutical, Cardiology, Biotechnology, FDA, Insurance, Standard of care, Research, Trial of the century, American College, First, Aircraft registration, American Gastroenterological Association, FSS, PDT, Food, AGA, Patent, ATM, Therapy, Regulation, Business development, Disclosure, Regulation of tobacco by the U.S. Food and Drug Administration, Type 2 diabetes, Marketing, Partnership, Webcast, Machine learning, Regulation Fair Disclosure, Better, Traction, CBT, Safety, AI, European, MASH, Patient, Prescription, Veteran, VA, Cognitive behavioral therapy, Pharmaceutical industry, Health insurance, Bank, T2D, EU

New Patent Issued: In September 2023, Better Therapeutics patent - "Managing lifestyle and health interventions with predictive analytics" - was issued in the European Union (EU).

Key Points: 
  • New Patent Issued: In September 2023, Better Therapeutics patent - "Managing lifestyle and health interventions with predictive analytics" - was issued in the European Union (EU).
  • Showcased AspyreRx at First Promotional Meeting: In October 2023, Better Therapeutics announced its participation at the American College of Lifestyle Medicine’s 2023 Annual Meeting.
  • Further Strengthen Financial Position: Better Therapeutics expects to further strengthen its financial position in the fourth quarter to extend its financial runway.
  • Better Therapeutics periodically provides other information for investors on its corporate website, http://www.bettertx.com , and its investor relations website, https://investors.bettertx.com .

The Inner Circle Acknowledges, Dr. Susan T. Wolgamott, DNP, FNP-C, CTN-B as a Top Pinnacle Healthcare Professional for her contributions to the field of Gastroenterology

Retrieved on: 
Tuesday, October 17, 2023
Faculty, Arizona State University Downtown Phoenix campus, American Association of Nurse Practitioners, American College, Geriatrics, Associate, Health, Nurse practitioner, Life, Reading, MD, RN, Certification, Practice, Multimedia, Crohn's disease, Injury, Inner circle, IBS, Crohn's & Colitis Foundation, American College of Gastroenterology, DNP, Love, IBD, University, Ferris State University, Music, Irritable bowel syndrome, American Gastroenterological Association, University of Michigan–Flint, Chron, Inflammatory bowel disease, Pediatrics, Emergency medicine, ICU, Nursing, Science, Gastroenterology

SHELBY TOWNSHIP, Mich., Oct. 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Susan T. Wolgamott, DNP, FNP-C, CTN-B is acknowledged as a Top Pinnacle Healthcare Professional for her contributions to the field of Gastroenterology.

Key Points: 
  • SHELBY TOWNSHIP, Mich., Oct. 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Susan T. Wolgamott, DNP, FNP-C, CTN-B is acknowledged as a Top Pinnacle Healthcare Professional for her contributions to the field of Gastroenterology.
  • Later in 2010, she attended the University of Phoenix and received a Bachelor of Applied Science in Nursing.
  • She also served as a respected lecturer and professor at the University of Michigan-Flint from September 2011 to September 2020.
  • Dr. Wolgamott is a distinguished founding member and esteemed faculty of the Gastroenterology and Hepatology Advanced Practice Providers Organization.

InterVenn Biosciences Announces the Publication of Early Detection of Advanced Adenoma and Colorectal Cancer in Gastroenterology, the Flagship Journal of the American Gastroenterological Association

Retrieved on: 
Friday, October 13, 2023
Technology, Medical Devices, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, Artificial Intelligence, Oncology, Diagnosis, NN, Partnership, Biomarker, Biology, Colorectal cancer, Receiver, CRC, Artificial intelligence, Workflow, Patient, AA, American Gastroenterological Association, Carolyn Bertozzi, Shaukat Khanum Memorial Cancer Hospital and Research Centre, LC-MS, Data analysis, Operating point, FP, Cancer, Research, Pharmaceutical industry, Medical imaging, Gastroenterology

InterVenn Biosciences , a life sciences company pioneering glycoproteomics, today announced the publication of their discovery work in Advanced Adenoma (AA) and Colorectal Cancer (CRC) early disease detection in the flagship journal of the American Gastroenterological Association, Gastroenterology.

Key Points: 
  • InterVenn Biosciences , a life sciences company pioneering glycoproteomics, today announced the publication of their discovery work in Advanced Adenoma (AA) and Colorectal Cancer (CRC) early disease detection in the flagship journal of the American Gastroenterological Association, Gastroenterology.
  • This groundbreaking research in early detection of CRC represents an advancement in early diagnosis through serum glycoproteome profiling.
  • The results published in Gastroenterology establish the groundwork for a blood-based CRC screening modality using artificial intelligence to reveal the earliest stages of colorectal cancer.
  • Desai K, Gupta S, May FP, Xu G, Shaukat A, Hommes DW, NICE-AA/CRC- Consortium, Early detection of advanced adenomas and colorectal carcinoma by serum glycoproteome profiling., Gastroenterology (2023), doi: https://doi.org/10.1053/j.gastro.2023.09.034